Analisi costo-utilità di dupilumab per il trattamento della dermatite atopica grave negli adulti in Italia

BACKGROUND: Atopic dermatitis (AD) is a chronic, multifactorial, inflammatory skin disease with significant impact on patients’ quality of life. OBJECTIVE: The objective of this analysis was to estimate the incremental cost-utility ratio (ICUR) of dupilumab, administered every other week, plus suppo...

Descripción completa

Detalles Bibliográficos
Autores principales: Costanzo, Antonio, Furneri, Gianluca, Bitonti, Rossella, Pedone, Maria Paola, Fanelli, Francesca, Di Turi, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677604/
https://www.ncbi.nlm.nih.gov/pubmed/36627954
http://dx.doi.org/10.33393/grhta.2020.710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677604/
https://www.ncbi.nlm.nih.gov/pubmed/36627954
http://dx.doi.org/10.33393/grhta.2020.710

Ejemplares similares